Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
We review your health history, your goals, and what you have already tried
No difference from baseline was seen at 20 and 26 weeks
University of California patents underlying enzalutamides development became subjects of public debate regarding pharmaceutical pricing when the originator companies argued that the patents expiration timeline justified pricing above $100,000 annually per patient
Unregulated, potentially dangerous, and illegal
6, 5 Sept
US$ 29.87
US$ 29.57
US$ 20.39
US$ 22.34
US$ 24.26
US$ 20.45
US$ 27.53
